MARCKSL1–2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b

Press/Media: Press / Media

PeriodJul 21 2022

Media coverage

1

Media coverage

  • TitleMARCKSL1–2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b
    Media name/outletMOLECULAR CANCER
    Country/TerritoryUnited Kingdom
    Date7/21/22
    PersonsXianlian Zhou
View all 1
View less